Literature DB >> 7693384

IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia.

A L'Abbate1, S Cutrupi, M Rognetta, C Fabiano, A Craxi.   

Abstract

To assess the relationship between hepatitis C virus (HCV) infection and essential mixed cryoglobulinaemia (EMC), sera from 23 patients with EMC were tested for IgG and IgM antibodies to HCV antigens and for HCV RNA. Quantitative HCV antibody studies were performed on serum and purified cryoglobulin fractions. HCV antibodies of both IgG and IgM class were found in 22 (96%) patients. Ten of these were also HCV-RNA positives. Higher titres of anti-HCV IgM were present in the 11 patients with evidence of liver damage. Anti-HCV IgG antibodies were shown to be concentrated in the IgG fraction of cryoglobulins in all eight patients studied. These results strongly suggest a role for HCV in the pathogenesis of EMC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693384      PMCID: PMC1534243          DOI: 10.1111/j.1365-2249.1993.tb03449.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Hepatitis C virus in patients with cryoglobulinemia type II.

Authors:  M Pascual; L Perrin; E Giostra; J A Schifferli
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

2.  Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia.

Authors:  C Ferri; F Greco; G Longombardo; P Palla; A Moretti; E Marzo; P V Fosella; G Pasero; S Bombardieri
Journal:  Arthritis Rheum       Date:  1991-12

3.  Association between hepatitis C virus and mixed cryoglobulinemia [see comment].

Authors:  C Ferri; F Greco; G Longombardo; P Palla; A Moretti; E Marzo; A Mazzoni; G Pasero; S Bombardieri; P Highfield
Journal:  Clin Exp Rheumatol       Date:  1991 Nov-Dec       Impact factor: 4.473

4.  Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

Authors:  M Meltzer; E C Franklin; K Elias; R T McCluskey; N Cooper
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

5.  Glomerular localization of circulating antiglobulin activity in essential mixed cryoglobulinemia with glomerulonephritis.

Authors:  Q Maggiore; F Bartolomeo; A L'Abbate; V Misefari; C Martorano; A Caccamo; G B di Belgiojoso; A Tarantino; G Colasanti
Journal:  Kidney Int       Date:  1982-02       Impact factor: 10.612

6.  Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.

Authors:  S Magrin; A Craxì; C Fabiano; G Fiorentino; L Marino; P Almasio; G B Pinzello; U Palazzo; M Vitale; A Maggio
Journal:  J Med Virol       Date:  1992-11       Impact factor: 2.327

7.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus.

Authors:  K Yoshioka; S Kakumu; T Wakita; T Ishikawa; Y Itoh; M Takayanagi; Y Higashi; M Shibata; T Morishima
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

8.  Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C.

Authors:  S Brillanti; C Masci; P Ricci; M Miglioli; L Barbara
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425

9.  Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 10.  Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients.

Authors:  P D Gorevic; H J Kassab; Y Levo; R Kohn; M Meltzer; P Prose; E C Franklin
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

View more
  2 in total

1.  Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins.

Authors:  B-N Pham; M Martinot-Peignoux; M-P Ripault; N Boyer; V Levy; P Marcellin
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

2.  Levels of hepatitis C virus (HCV) RNA in serum and their relationship to levels of immunoglobulin M and G antibodies against HCV core protein.

Authors:  M Chen; A Sönnerborg; M Sällberg
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.